For much of modern biology, genes have occupied center stage. DNA provides instructions. Proteins carry them out. Cells assemble into tissues and organs. But this familiar explanation leaves an extraordinary problem unresolved:
How do trillions of cells know what they are supposed to build – and when to stop?
Michael Levin’s research has made that question impossible to ignore.
At Tufts University, Levin’s laboratory studies morphogenesis: how collections of cells build, repair and sometimes regenerate complex anatomical structures. His work examines cellular bioelectric networks and how electrical states can participate in storing and communicating information about biological form.
This is not simply the familiar electrical activity of nerves. Bioelectric signaling exists in non-neural tissues as well. Cells maintain voltage gradients across their membranes, communicate through ion channels and gap junctions, and participate in collective electrical states.
It is a profound shift in perspective. The body is not merely chemistry occurring inside a genetically constructed machine. It is also an electrical information network.
If biological organization is partly electrical, then developing better ways to measure electrical physiology in humans could open an entirely new window into health and disease.
Levin’s research asks us to think differently about biological organization. A salamander can regenerate a limb. An embryo can compensate for dramatic disturbances during development. Tissues somehow detect that a structure is incomplete and coordinate activity toward restoration.
Levin has described aspects of this in terms of goal-directed biological behavior and anatomical homeostasis – cellular collectives working toward particular structural outcomes.
If that framework is correct, an important medical implication follows. Disease may sometimes represent more than molecular damage. It may also involve disruption in biological information and coordination.
Cancer provides an obvious conceptual example: cells that once participated cooperatively in the organism begin behaving according to a radically different set of priorities. Regeneration presents the opposite problem: how can cells be persuaded to recover the correct collective program?
Those questions place bioelectricity alongside genetics and biochemistry as a potentially important layer of biological control.
This is where a major translational gap appears. Levin’s laboratory has developed remarkable experimental methods for examining cellular voltage patterns in developmental organisms and tissues. Translating such concepts into whole-human measurement is another challenge entirely.
Medicine has excellent methods for measuring specialized electrical phenomena: ECG for the heart, EEG for the brain, EMG for muscle. But these instruments were designed around particular organs and particular electrical events.
They were not designed to ask: Does the organism possess a broader physiological electrical signature?
That question is closely related to the scientific territory Aurorus is attempting to explore.
Aurorus does not claim to measure Levin’s morphogenetic fields, nor should it. The scientifically responsible proposition is more interesting: Can a rapid, non-invasive electrophysiological/photonic measurement provide reproducible information about systemic physiological state?
And if it can, how does that information relate to cellular metabolism, oxidative processes, autonomic regulation, disease and recovery?
A collaboration between work inspired by Levin’s bioelectric research and a measurement platform such as Aurorus would not begin by trying to prove a philosophical theory. It would begin with experiments.
Could electrophysiological patterns change during injury and recovery? Could they correlate with conventional measures of tissue dysfunction? Do therapeutic interventions that influence cellular physiology generate detectable systemic changes? Are those changes consistent across people? Do certain patterns precede conventional biochemical markers? And, perhaps most importantly, can the measurements be independently reproduced?
These questions would help create a bridge between fundamental bioelectric biology and whole-human physiology.
Levin’s work has already expanded the concept of biological computation beyond neurons. That may eventually force medicine to expand its own concept of measurement.
The twentieth century became exceptionally good at measuring biological structure. The twenty-first century may need to become equally sophisticated at measuring biological state.
Structure tells us what the body looks like. Chemistry tells us what molecules are present. Bioelectricity may help tell us what living systems are doing. If biological organization is partly electrical, then developing better ways to measure electrical physiology in humans could open an entirely new window into health and disease. Aurorus may ultimately be valuable not because it answers the bioelectric question – but because it gives us another way to ask it experimentally.
Michael Levin’s research suggests something both simple and revolutionary: cells do not merely contain information. They communicate and act upon it.
• Michael Levin Laboratory – drmichaellevin.org
• Tufts University / Allen Discovery Center – allen-discovery-center.tufts.edu
Note: This article presents research and strategic hypotheses for discussion. Proposed Aurorus applications are framed as testable research questions and are not intended as clinical claims.
Regulatory note: Aurorus is a non-invasive electrophysiological measurement platform. It was granted FDA De Novo classification (DEN150004) as a Class I non-invasive electrophysiological measurement device. It is not cleared for diagnostic purposes. Nothing in this article claims that any therapy, modality, or practice diagnoses, treats, cures, or prevents any disease.